During the past decade, Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept. conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept." #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Hellenic Cooperative Oncology Group" with 12 trials sponsored, "Amgen" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored and "Arcus Biosciences, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept." #1 collaborator was "Sanofi" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Care Across Ltd" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept." are "Breast Cancer" (4 trials), "Ovarian Cancer" (3 trials), "Triple-Negative Breast Cancer" (2 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials) and "Biliary Carcinoma" (1 trials). Many other conditions were trialed in "Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept." in a lesser frequency.

Most popular intervention types in "Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept." are "Drug" (31 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (9 trials), "Paclitaxel" (7 trials), "Carboplatin" (5 trials), "Bevacizumab" (3 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept." are 28 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept.". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept., 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".